• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia

cafead

Administrator
Staff member
  • cafead   Jun 07, 2022 at 10:22: AM
via Chronic kidney disease (CKD) often moves silently and unpredictably. It is one of the most common complications stemming from diabetes, with up to 40% of all diabetics ultimately battling the complication.

article source